When Silence

Open Questions

Each hypothesis tries to explain where tinnitus comes from, and each one leaves questions that future research has to answer before we know if it is right. Here are all 30 of them, grouped by hypothesis.

Acoustic Shock Syndrome

Read the hypothesis
  • Can tensor tympani muscle overuse or injury actually be measured in patients after an acoustic shock?
  • Does targeting the muscle or the trigeminal inflammation relieve the symptom cluster?
  • What fraction of chronic tinnitus with ear pain/fullness fits this model versus cochlear or central-gain mechanisms?

Dorsal Cochlear Nucleus Origin

Read the hypothesis
  • Which patient subtypes (e.g., somatic vs. non-somatic tinnitus) respond best to bimodal stimulation?
  • How durable is the benefit beyond the trial washout period, and is periodic re-treatment needed?
  • Can the DCN-level mechanism be combined with cortical approaches (e.g., PV interneuron targeting) for larger effects?
  • Could 5-HT2A antagonists, several of which are already approved for other conditions, reduce tinnitus in patients where a serotonergic contribution is present?

PV Interneuron Dysfunction

Read the hypothesis
  • Does 40 Hz PVN stimulation durably relieve the tinnitus percept itself, not just loudness hyperacusis?
  • Can a non-invasive stimulation method (e.g., transcranial) reproduce the 'sticky' gain effect seen with direct cortical PVN activation in mice?
  • How long does PVN hypofunction persist after cochlear injury, and is there a treatment window?
  • If central gain is an adaptive, homeostatic response, why do only some people with hearing loss develop tinnitus or hyperacusis?
  • Can central gain be measured reliably in an individual patient, well enough to guide treatment?
  • Which level of the pathway (brainstem, midbrain, cortex) contributes most to the gain increase, and can it be selectively turned down?

Interacting Brain Networks

Read the hypothesis
  • Is the 'tinnitus core' subnetwork the same across patients, or does each person have a different core?
  • Thalamocortical dysrhythmia also appears in Parkinson's, pain and depression, what makes the tinnitus form specifically auditory?
  • Can normalising the thalamocortical rhythm abolish the percept itself, rather than only the distress that accompanies it?
  • If amygdala-to-auditory-cortex connectivity tracks distress, could directly targeting that connection (rather than the auditory pathway) relieve tinnitus-related suffering without changing the perceived loudness?
  • Are the Default Mode Network and Salience Network changes a cause of tinnitus distress, or a consequence of living with a persistent phantom sound?

Cochlear Synaptopathy

Read the hypothesis
  • Can cochlear synaptopathy be reliably diagnosed in an individual living patient? Sex-adjusted ABR Wave I amplitude norms can now flag likely deafferentation at a group level, but only around half of high-risk patients fall outside the normal range, so a dependable individual-level test still doesn't exist. One candidate marker has since been ruled out: the middle ear muscle reflex was not consistently reduced in Veterans whose ABR and envelope following responses both pointed to deafferentation, and some had unusually large reflexes, so it does not appear trustworthy on its own.
  • Does synaptopathy alone (without hair cell loss) directly cause tinnitus and hyperacusis, or does it only set the stage for downstream central changes? Isolating the two is proving difficult in real patients: Veterans with tinnitus or reduced sound tolerance and normal audiograms showed deafferentation markers together with subclinical high frequency outer hair cell dysfunction, so the peripheral damage is mixed rather than purely synaptic, and their elevated wave V/I ratios suggest brainstem amplification is doing part of the work.
  • Can lost synapses be regenerated therapeutically (e.g., neurotrophin treatment) to reverse hidden hearing loss?

Potassium Channel Dysfunction

Read the hypothesis
  • Can Kv7/KCNQ channel activity be measured non-invasively in humans to identify who is vulnerable to tinnitus after noise exposure?
  • Do clinical Kv7 openers already in human development for epilepsy and depression (e.g., XEN1101/Azetukalner) reduce tinnitus? None has yet been tested in a dedicated tinnitus trial.
  • Why do some animals spontaneously restore KCNQ2/3 activity (resilience) while others don't?

Cortical Tonotopic Map Reorganization

Read the hypothesis
  • Does the cortical map shift itself generate the tinnitus percept, or is it mostly a byproduct/marker of how much hearing loss occurred?
  • Could a human equivalent of the animal 'enriched acoustic environment' (tailored sound therapy matched to a person's hearing-loss frequencies) prevent or reverse map reorganization and reduce tinnitus?
  • Is the loss of cortical inhibition that enables map reorganization the same mechanism implicated in PV interneuron dysfunction, or a separate process that happens to produce a similar effect?

Central Neuroinflammation

Read the hypothesis
  • Does blocking TNF-α or dampening microglial activation reduce established tinnitus in humans, not just prevent it in mice?
  • Is the neuroinflammation a primary cause of tinnitus, or a secondary response that amplifies damage from other mechanisms?
  • Which patients have an inflammatory tinnitus subtype that would respond to anti-inflammatory treatment, and can a blood or imaging biomarker identify them?